Amtagvi® and its accompanying design marks, Proleukin®, Iovance®, and IovanceCares™ are trademarks and registered trademarks of Iovance Biotherapeutics, Inc. or its subsidiaries. All other trademarks ...

The option has an exercise price equal to the closing price of Autonomix’s common stock as reported by the Nasdaq Capital Market on March 17, 2025. The options have a ten-year term and vest in four ...

European Wax Center, Inc. (NASDAQ: EWCZ) (the “Company” or “European Wax Center”), the leading franchisor and operator of out ...

Immuneering is a clinical-stage oncology company seeking to develop and commercialize more effective and better tolerated therapies for cancer patients. The Company’s lead product candidate, IMM-1-104 ...

Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 147,500 shares of common ...

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, ...

Robot Corp. (NASDAQ: IRBT), a leader in consumer robots, today announced that it granted an equity award as a material inducement to the employment of the company's newly-hired Senior Vice President ...

The approved inducement grant comes as Etsy targets a stickier app experience as part of a strategy to reverse an ongoing ...

These inducement stock options and inducement RSUs are subject ... the closing price of Travere’s common stock on the date of grant, are non-qualified stock options, have a 10-year term and vest over ...

The inducement equity awards were granted effective as of March ... price of Ocular’s common stock on The Nasdaq Global Market on the effective date of grant, and (ii) a restricted stock unit award ...

Gossamer Bio, Inc. (Nasdaq: GOSS), a late-stage, clinical biopharmaceutical company focused on the development and commercialization of seralutinib fo ...